| Identification | Back Directory | [Name]
N-[(1S)-1-(aminocarbonyl)-2-methylpropyl]-1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamide | [CAS]
1185282-01-2 | [Synonyms]
AB-FUBINACA
(S)-AB-FUBINACA
AB-FUBINACA, PX-4
AB-FUBINACA (CRM)
AB-FUBINACA solution
N-[(1S)-1-carbamoyl-2-methyl-propyl]-1-[(4-fluorophenyl)methyl]indazole-3-carboxamide
(S)-N-(1-aMino-3-Methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxaMide
N-[(1S)-1-(aMinocarbonyl)-2-Methylpropyl]-1-(4-fluorobenzyl)-1H-indazole-3-carboxaMide
N-[(2S)-1-amino-3-methyl-1-oxobutan-2-yl]-1-[(4-fluorophenyl)methyl]indazole-3-carboxamide
N-[(1S)-1-(aMinocarbonyl)-2-Methylpropyl]-1-[(4-fluorophenyl)Methyl]-1H-indazole-3-carboxaMide
1H-Indazole-3-carboxamide, N-[(1S)-1-(aminocarbonyl)-2-methylpropyl]-1-[(4-fluorophenyl)methyl]- | [EINECS(EC#)]
200-659-6 | [Molecular Formula]
C20H21FN4O2 | [MDL Number]
MFCD24368587 | [MOL File]
1185282-01-2.mol | [Molecular Weight]
368.4 |
| Hazard Information | Back Directory | [Uses]
N-[(1S)-1-(Aminocarbonyl)-2-methylpropyl]-1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamide is a indazole derivative developed as a CB1 receptor modulator used in the treatment of CB1-mediated dise
ases. |
|